Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash from Discontinued Operations (2018 - 2025)

Pediatrix Medical (MD) has disclosed Cash from Discontinued Operations for 8 consecutive years, with 502000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Discontinued Operations rose 72.03% to 502000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 3648000.0, a 65.83% increase, with the full-year FY2025 number at 3648000.0, up 65.83% from a year prior.
  • Cash from Discontinued Operations was 502000.0 for Q4 2025 at Pediatrix Medical, up from 830000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 16738000.0 in Q1 2021 to a low of 30806000.0 in Q4 2021.
  • A 5-year average of 3773750.0 and a median of 2497500.0 in 2024 define the central range for Cash from Discontinued Operations.
  • Peak YoY movement for Cash from Discontinued Operations: surged 104.81% in 2022, then crashed 853.11% in 2024.
  • Pediatrix Medical's Cash from Discontinued Operations stood at 30806000.0 in 2021, then soared by 88.29% to 3607000.0 in 2022, then dropped by 4.05% to 3753000.0 in 2023, then skyrocketed by 52.17% to 1795000.0 in 2024, then skyrocketed by 72.03% to 502000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Cash from Discontinued Operations are 502000.0 (Q4 2025), 830000.0 (Q3 2025), and 964000.0 (Q2 2025).